Allogene Therapeutics, Inc. (ALLO) Insider Trading

Name: Allogene Therapeutics, Inc. (ALLO) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 25, 2026): Earl Martin Douglas (SVP, General Counsel): Sale of 29,697 shares, $63.0K.

Get alerted when insiders trade ALLO

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta